LIXTE BIOTECHNOLOGY HOLDINGS, INC. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Lixte Biotechnology Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Lixte Biotechnology Holdings, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$983K, a 4% increase year-over-year.
  • Lixte Biotechnology Holdings, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$3.99M, a 30% increase year-over-year.
  • Lixte Biotechnology Holdings, Inc. annual Operating Income (Loss) for 2023 was -$5.09M, a 19.4% increase from 2022.
  • Lixte Biotechnology Holdings, Inc. annual Operating Income (Loss) for 2022 was -$6.31M, a 6.09% increase from 2021.
  • Lixte Biotechnology Holdings, Inc. annual Operating Income (Loss) for 2021 was -$6.72M, a 106% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$3.99M -$983K +$40.9K +4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$4.03M -$1.01M +$661K +39.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$4.69M -$967K +$403K +29.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$5.09M -$1.03M +$607K +37.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 -$5.7M -$1.02M +$454K +30.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$6.15M -$1.67M -$124K -8.02% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$6.03M -$1.37M +$284K +17.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$6.31M -$1.63M +$392K +19.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 -$6.7M -$1.48M -$241K -19.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$6.46M -$1.55M +$187K +10.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$6.65M -$1.65M +$70.8K +4.11% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$6.72M -$2.02M -$1.12M -124% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 -$5.6M -$1.24M +$364K +22.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$5.96M -$1.73M -$1.36M -364% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$4.6M -$1.73M -$1.34M -346% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$3.27M -$904K -$574K -174% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-21
Q3 2020 -$2.69M -$1.6M -$509K -46.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$2.18M -$373K +$254K +40.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$2.44M -$387K +$51.6K +11.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$2.49M -$330K +$21.5K +6.11% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-26
Q3 2019 -$2.51M -$1.09M -$58.6K -5.66% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$2.45M -$628K -$256K -68.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$2.2M -$439K -$59K -15.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$2.14M -$352K +$99.1K +22% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-25
Q3 2018 -$2.24M -$1.03M -$571K -123% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$1.67M -$372K -$79K -27% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 -$1.59M -$380K +$223K +37% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$1.81M -$451K +$65.2K +12.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-25
Q3 2017 -$1.88M -$463K +$184K +28.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$2.06M -$293K +$262K +47.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 -$2.32M -$603K -$186K -44.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-27
Q4 2016 -$2.13M -$516K +$97.6K +15.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-23
Q3 2016 -$2.23M -$647K +$133K +17% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$2.37M -$555K -$54.3K -10.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-04
Q1 2016 -$2.31M -$417K +$336K +44.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$2.65M -$614K +$54.8K +8.2% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-29
Q3 2015 -$2.7M -$780K -$278K -55.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 -$2.42M -$501K +$16.6K +3.21% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
Q1 2015 -$2.44M -$752K -$36.4K -5.08% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 -$2.4M -$669K -$310K -86.2% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-28
Q3 2014 -$2.09M -$501K -$188K -60.2% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 -$1.91M -$517K -$148K -40.3% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$1.76M -$716K -$382K -114% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q4 2013 -$1.37M -$359K -$83.3K -30.2% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-27
Q3 2013 -$1.29M -$313K +$525K +62.7% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 -$1.82M -$369K +$31.2K +7.8% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 -$1.85M -$334K +$258K +43.6% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 -$2.11M -$276K +$394K +58.9% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-21
Q3 2012 -$2.5M -$838K -$339K -67.9% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 -$2.16M -$400K -$52.2K -15% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-05
Q1 2012 -$2.11M -$592K -$241K -68.6% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$1.87M -$670K Oct 1, 2011 Dec 31, 2011 10-K 2013-03-15
Q3 2011 -$499K -$121K -31.8% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 -$348K -$37.8K -12.2% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-10
Q1 2011 -$351K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q3 2010 -$379K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-10
Q2 2010 -$310K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.